Product description
CG 210 is composed of natural botanical ingredients, ensuring its safety without any known adverse effects.
Repeated premature shifts to the catagen phase, driven by extensive apoptosis (cell death), and increasingly shorter anagen phases result in hair miniaturization, often referred to as male pattern baldness. Alongside apoptosis, excessive hair loss is also linked to inflammation in the scalp.
Clinical trials conducted on individuals with androgenetic alopecia using CG 210 have shown the following advantages. In a publicly available scalp biopsy study involving subjects with androgenetic alopecia, the daily use of CG 210 for three months restored the levels of an anti-apoptotic protein to those found in individuals without hair loss. This restoration of the anti-apoptotic protein's levels should help retain more hair in the growth phase (anagen) and delay the premature transition to the shedding phase (catagen). As long as the product is applied consistently, excessive hair loss may no longer be a concern.